OPKO Health, Inc. (OPK) compared with its closest peers (INSM, TGTX, AXSM, ORGO, RARE). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Insmed, TG Therapeutics, Axsome Therapeutics, Organogenesis, Ultragenyx Pharmaceutical, Mirum Pharmaceuticals, Amphastar Pharmaceuticals, Emergent BioSolutions, Travere Therapeutics and Corcept Therapeutics share OPKO Health's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| TG Therapeutics, Inc. (TGTX) | $8.31B | 18.7 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Organogenesis Holdings Inc. (ORGO) | $231.61M | 34.5 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| Mirum Pharmaceuticals, Inc. (MIRM) | $5.87B | -168.0 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | $952.41M | 15.7 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Travere Therapeutics, Inc. (TVTX) | $6.11B | -131.8 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
OPK overview · OPK earnings · OPK financials · OPK KPIs · OPK documents · OPK ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.